Delanzomib
Delanzomib is an orally active inhibitor of the chymotrypsin-like activity of proteasome with IC50 of 3.8 nM, with only marginal inhibition of the tryptic and peptidylglutamyl activities of the proteosome. Phase 1/2.
| Trivial name | CEP-18770 |
| Catalog Number | S1157 |
| Molecular Formula | C19H18O9 |
| CAS# | 847499-27-8 |
| Inchi | InChI=1S/C19H18O9/c1-22-11-4-9(6-20)13(17-15(11)25-7-27-17)14-10(19(21)24-3)5-12(23-2)16-18(14)28-8-26-16/h4-5,20H,6-8H2,1-3H3 |
| Inchi Key | KXMTXZACPVCDMH-UHFFFAOYSA-N |
| SMILES | COC1=C2C(=C(C(=C1)CO)C3=C4C(=C(C=C3C(=O)OC)OC)OCO4)OCO2 |
| Size | 5mg |
| Supplier Page | http://www.selleckchem.com/products/cep-18770.html |
| Additional Information | https://file.selleck.cn/downloads/struct/CEP-18770-chemical-structure-s1157.gif |